Aromatherapy and Massage After Cesarean Delivery: A Randomized Controlled Trial
Effects of Aromatherapy and Massage on Pain, Anxiety, and Comfort After Cesarean Delivery: A Randomized Controlled Trial
1 other identifier
interventional
90
1 country
1
Brief Summary
Cesarean delivery is a common surgical procedure associated with postoperative pain, anxiety, and reduced maternal comfort during the early postpartum period. Non-pharmacological interventions such as aromatherapy and massage have been suggested as supportive approaches for improving maternal well-being; however, further evidence is needed regarding their effectiveness after cesarean delivery. This randomized controlled trial aims to evaluate the effects of aromatherapy inhalation and aromatherapy-assisted back massage on postoperative pain, anxiety, and postpartum comfort in women after cesarean delivery. Participants who meet the eligibility criteria will be randomly assigned to three groups: an aromatherapy inhalation group, an aromatherapy-assisted back massage group, and a placebo group receiving sterile water inhalation as a simulation. Interventions will be initiated after cesarean delivery, and outcomes will be assessed using the Visual Analog Scale for pain intensity, the State-Trait Anxiety Inventory for anxiety level, and the Postpartum Comfort Scale for comfort level. This study is expected to provide information about the potential contribution of complementary non-pharmacological interventions to maternal recovery after cesarean delivery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2026
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 23, 2026
CompletedFirst Submitted
Initial submission to the registry
July 29, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2026
CompletedFirst Posted
Study publicly available on registry
August 4, 2026
CompletedAugust 4, 2026
July 1, 2026
5 months
July 29, 2026
July 29, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative pain intensity
Pain intensity will be assessed using the Visual Analog Scale (VAS), a 0-10 scale in which higher scores indicate greater pain intensity.
From 6 to 42 hours after cesarean delivery (before and after each intervention session)
Secondary Outcomes (2)
Anxiety level
Before the first intervention session and after the final intervention session (42 hours after cesarean delivery).
Postpartum comfort level
Before the first intervention session and after the final intervention session (42 hours after cesarean delivery).
Study Arms (3)
Aromatherapy Inhalation Group
EXPERIMENTALParticipants in this group will receive aromatherapy inhalation beginning at the 6th postoperative hour after cesarean delivery. The intervention will be administered at 6, 18, 30, and 42 hours after surgery using Rosa damascena essential oil according to the study protocol. Pain, anxiety, and postpartum comfort outcomes will be assessed before and after the intervention sessions according to the study protocol.
Aromatherapy-Assisted Back Massage Group
EXPERIMENTALParticipants in this group will receive aromatherapy-assisted back massage starting at the 6th postoperative hour after cesarean delivery. The intervention will be administered at 6, 18, 30, and 42 hours after surgery. Back massage will be performed using Rosa damascena essential oil diluted with a carrier oil according to the study protocol. Pain, anxiety, and postpartum comfort outcomes will be assessed before and after each intervention session.
Placebo Group
PLACEBO COMPARATORParticipants in this group will receive placebo inhalation beginning at the 6th postoperative hour after cesarean delivery. The intervention will be administered at 6, 18, 30, and 42 hours after surgery using sterile water as a simulation of aromatherapy according to the study protocol. Pain, anxiety, and postpartum comfort outcomes will be assessed before and after the intervention sessions according to the study protocol.
Interventions
Participants will receive aromatherapy inhalation using Rosa damascena essential oil beginning at the 6th postoperative hour after cesarean delivery. For each session, 2 drops of Rosa damascena essential oil will be applied to a sterile gauze and held approximately 10 cm from the participant's nose. Participants will breathe normally during the inhalation period. The intervention will be performed at 6, 18, 30, and 42 hours after surgery, with each session lasting 10 minutes.
Participants will receive aromatherapy-assisted back massage beginning at the 6th postoperative hour after cesarean delivery. The massage will be applied to the upper and lower back regions using Rosa damascena essential oil diluted to 3% with sweet almond carrier oil. The intervention will be performed at 6, 18, 30, and 42 hours after surgery according to the study protocol. Participants will be positioned in a comfortable lateral or sitting position during the massage application.
Participants will receive placebo inhalation using sterile water as a simulation of aromatherapy. The intervention will begin at the 6th postoperative hour after cesarean delivery and will be administered at 6, 18, 30, and 42 hours after surgery. Each session will follow the same procedure and duration as the aromatherapy inhalation group according to the study protocol.
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- Uşak Universitylead
Study Sites (1)
Usak University Training and Research Hospital
Uşak, Uşak, 64200, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr
Study Record Dates
First Submitted
July 29, 2026
First Posted
August 4, 2026
Study Start
February 23, 2026
Primary Completion
July 31, 2026
Study Completion
July 31, 2026
Last Updated
August 4, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share